Reflex Sympathetic Dystrophy
RSD / CRPS Treatment Center and Research Institute

The RSD / CRPS Treatment Center and Research Institute in Tampa, Florida is dedicated exclusively to RSD / CRPS. It is the world's first institute of its kind. The Institute opened its Center in February 2008, which is approved by the Florida Board of Medicine for Level II surgery.

Reflex Sympathetic Dystrophy, known as RSD, is a chronic neurological disorder that affects millions of people around the world. This disorder is also known as Complex Regional Pain Syndrome or CRPS.

Some of the treatments include a 3-day infusion with IV ketamine on an outpatient basis that is critical and not readily available elsewhere in the USA.

Additionally, there are children who suffer from RSD / CRPS and receive treatments that are only available through the Institute.
The Institute, under the direction of Anthony Kirkpatrick MD, PhD, devotes significant efforts to educating physicians worldwide on RSD / CRPS.

The Center provides free follow-up evaluations for research subjects engaged in its research studies.



After nearly twenty years of dedicated service to the University of South Florida College of Medicine in Tampa, Anthony F. Kirkpatrick, MD, PhD, left to establish the RSD / CRPS Treatment Center and Research Institute, the world's first institute of its kind, dedicated exclusively to RSD / CRPS. The Institute opened its Center in February 2008 and is headquartered in Tampa.

According to Dr. Robert Schwartzman at Drexel University, “There is a desperate need for a center of excellence for RSD treatment and research."

Dr. Kirkpatrick has devoted his life to the fight against RSD. He has been the recipient of awards from Florida Governors Jeb Bush and Bob Martinez, and from several Deans of the College of Medicine for his accomplishments while at USF.

In 2002, the Dean recognized his service and gave him an award for being an "outstanding employee who exemplifies the work ethic and commitment that has helped to make the College of Medicine and the Health Science Center a success”.


Foundation Video Tours: To learn more about our Headquarters and Surgery Center in Tampa, Florida USA








How to Determine the Effectiveness of Treatments for RSD / CRPS
Dr. Anthony F. Kirkpatrick, Chairman, Scientific Advisory Committee.

Ketamine Coma Procedure
Efficacy of Ketamine in Anesthetic Dosage for the Treatment of Refractory Complex Regional Pain Syndrome: An Open-Label Phase II Study.

Medical Synopsis for the Ketamine Coma Study
Research subjects discuss the risks and benefits of the ketamine coma procedure. This information is presented for patients who may be contemplating the procedure.

3-Day Outpatient High-Dose Ketamine Treatment
Understand more about this treatment

Sympathetic Blocks: An Overview
Learn about sympathetic pain blocks in this video.

High-Dose Ketamine Coma
Understand more about this research study.

Use of Opioids (Narcotics) to Treat RSD / CRPS in Children & Adults
Watch to learn more about this treatment procedure






Hosted By Bay Business Edge




Original text